Lizbeth C. DeSelm is an accomplished medicinal chemist with over 20 years of experience in drug discovery, spanning small molecules, PROTACs, and macrocycles. She has co-authored 17 patents and publications and contributed to the nomination of five clinical candidates across oncology, immunology, and inflammation. Throughout her career, Lizbeth has successfully driven cross-functional program to success, while managing multi-million dollar CRO accounts. Currently serving as the Partnerships Lead at Inductive Bio, she leverages her deep scientific expertise and strategic leadership to bridge advanced computational technologies with critical drug discovery pipelines.